Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

82.6K
Overview
82.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.7K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

14.3K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.3K
Antigen Presenting Cells01:22

Antigen Presenting Cells

2.7K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
2.7K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

15.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer.

PLoS biology·2026
Same author

The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM.

Cell·2026
Same author

Decoding the Cryptic Proteome Between Antigens and Novel Functional Proteins.

European journal of immunology·2025
Same author

Aryl hydrocarbon receptor restrains tonic cytokine responses by inhibiting microbiota sensing in monocytes.

The Journal of clinical investigation·2025
Same author

Transposon invasion of primate genomes shaped human inflammatory enhancers and susceptibility to inflammatory diseases.

Nature communications·2025
Same author

Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance.

Cancer immunology research·2025

Related Experiment Video

Updated: Dec 12, 2025

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.3K

A dendritic cell multitasks to tackle cancer

Marianne Burbage, Sebastian Amigorena

    Nature
    |August 14, 2020
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    CancerImmunology

    More Related Videos

    Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
    08:40

    Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

    Published on: August 1, 2013

    18.5K
    Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
    12:43

    Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

    Published on: January 6, 2014

    12.1K

    Related Experiment Videos

    Last Updated: Dec 12, 2025

    Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
    10:04

    Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

    Published on: August 1, 2025

    1.3K
    Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
    08:40

    Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

    Published on: August 1, 2013

    18.5K
    Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
    12:43

    Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

    Published on: January 6, 2014

    12.1K